3 ‘Buy’ recommendations by Motilal Oswal, with up to 31% upside potential
Motilal Oswal is optimistic about Larsen & Toubro, Gland Pharma, and Kotak Mahindra Bank, anticipating a maximum of 18% gains. L&T's robust order book is a big trigger while Gland Pharma is predicted to boost profits by investing in niche US approvals and expanding capacity. Kotak Mahindra Bank is concentrating on retail and SME sectors, with projected NII growth and reduced credit expenses.